(Q71901662)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

title

Inhibition of monoamine oxidases by haloperidol and its metabolites: pharmacological implications for the chemotherapy of schizophrenia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference

1 reference

1 reference

J Fang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

P H Yu

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

J W Gorrod

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

A A Boulton

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

publication date

1 March 1995

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

number of pages

7

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

volume

118

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

page(s)

206-212

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

Low platelet MAO activity in chronic schizophrenics: A long-term effect of neuroleptic treatment?

22 October 2019

cites work

1 reference

12 December 2020

Reduced monoamine oxidase activity in blood platelets from schizophrenic patients.

1 reference

12 December 2020

Phenylethylamine in paranoid chronic schizophrenia

1 reference

12 December 2020

Low platelet monoamine oxidase activity and schizophrenia

1 reference

12 December 2020

Biological and Behavioral Consequences of Alterations in Monoamine Oxidase Activity

1 reference

12 December 2020

Biochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics

1 reference

12 December 2020

Monamine oxidase in schizophrenia and other behavioral disorders

1 reference

12 December 2020

Kinetic analysis of platelet monoamine oxidase in chronic schizophrenia

1 reference

12 December 2020

Human platelet MAO in drug-free and medicated schizophrenic patients

1 reference

12 December 2020

Turnover of brain monoamine oxidase measured in vivo by positron emission tomography using L-[11C]deprenyl

1 reference

12 December 2020

Factors associated with decreased platelet MAO activity in chronic schizophrenics

1 reference

12 December 2020

Studies on the pargyline-binding site of different types of monoamine oxidase

1 reference

12 December 2020

The lessons of platelet monoamine oxidase.

1 reference

12 December 2020

Platelet monoamine oxidase activity in schizophrenia: a review of the data.

1 reference

12 December 2020

Distribution, excretion and metabolism of neuroleptics of the butyrophenone type. I. Excretion and metabolism of haloperidol and nine related butyrophenone-derivatives in the Wistar rat

1 reference

12 December 2020

Reduction of Blood Platelet Monoamine Oxidase Activity in Schizophrenic Patients on Phenothiazines

1 reference

12 December 2020

Effect of chlorpromazine treatment on monoamine oxidase activity in platelets isolated by the Corash method

1 reference

12 December 2020

High-performance liquid chromatographic method for the detection and quantitation of haloperidol and seven of its metabolites in microsomal preparations

1 reference

12 December 2020

Platelet monoamine oxidase activity in schizophrenia. Relationship to disease, treatment, institutionalization and outcome

1 reference

12 December 2020

Platelet monoamine oxidase activity and genetic vulnerability to schizophrenia

1 reference

12 December 2020

Neuroleptic drug effect on platelet monoamine oxidase and plasma amine oxidase in schizophrenia

1 reference

12 December 2020

Use of antisera in the isolation of human specific conjugates of haloperidol

1 reference

12 December 2020

Determination of the pyridinium metabolite derived from haloperidol in brain tissue, plasma and urine by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Genetics of platelet MAO activity in discordant schizophrenic and normal twins

1 reference

12 December 2020

Comparison of biochemical properties of platelet monoamine oxidase in mentally disordered and healthy individuals.

1 reference

12 December 2020

Chronic neuroleptics and brain monoamine oxidase activity

1 reference

12 December 2020

Platelet monoamine oxidase activity in schizophrenia

1 reference

12 December 2020

Factors Affecting Determination of Platelet Monoamine Oxidase Activity

1 reference

12 December 2020

Platelet MAO in schizophrenics: relationship to symptomatology and neuroleptics

1 reference

12 December 2020

Haloperidol inhibition of monoamine oxidase in vivo and in vitro

1 reference

12 December 2020

Neuroleptic-induced decrease in platelet MAO activity of schizophrenic patients

1 reference

12 December 2020

Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats

1 reference

12 December 2020

Platelet Monoamine Oxidase Activity in Acute Schizophrenia: Relationship to Symptomatology and Neuroleptic Medication

1 reference

12 December 2020

Analogues of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as monoamine oxidase substrates: a second ring is not necessary

1 reference

12 December 2020

Platelet monoamine oxidase activity in schizophrenia: relationship to family history of the illness and neuroleptic treatment

1 reference

12 December 2020

Platelet monamine oxidase in chronic schizophrenia. Some enzyme characteristics relevant to reduced activity

1 reference

12 December 2020

Platelet glutathione peroxidase and monoamine oxidase activity in schizophrenics with CT scan abnormalities: relation to psychosocial variables

1 reference

12 December 2020

A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients

1 reference

12 December 2020

Platelet monamine oxidase in schizophrenia. An investigation in drug-free chronic hospitalized patients

1 reference

12 December 2020

Differences in platelet monoamine oxidase activity in subgroups of schizophrenic and depressive disorders

1 reference

12 December 2020

Effect of neuroleptic drugs on platelet monoamine oxidase in psychiatric patients

1 reference

12 December 2020

Platelet monoamine-oxidase activity in schizophrenia. Relation to genetic load of the illness and treatment with antipsychotic drugs

1 reference

12 December 2020

Studies on the in vitro conversion of haloperidol to a potentially neurotoxic pyridinium metabolite

1 reference

12 December 2020

2-Phenylethylamine: a modulator of catecholamine transmission in the mammalian central nervous system?

1 reference

12 December 2020

Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP

1 reference

12 December 2020

Dehydration is the first step in the bioactivation of haloperidol to its pyridinium metabolite

1 reference

12 December 2020

Human platelet monoamine oxidase activity in health and disease: a review

1 reference

12 December 2020

On the metabolism of haloperidol

1 reference

12 December 2020

Effects of neuroleptics on platelet monoamine oxidase activity

1 reference

12 December 2020

Low platelet MAO activity and schizophrenia: sex differences.

1 reference

12 December 2020

Platelet monoamine oxidase activity in schizophrenic patients

1 reference

12 December 2020

Plasma phenylethylamine in schizophrenic patients

1 reference

12 December 2020

Plasma levels of phenylacetic acid, m- and p-hydroxyphenylacetic acid, and platelet monoamine oxidase activity in schizophrenic and other patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:7617809%20AND%20SRC:MED&resulttype=core&format=json

22 October 2019

1 reference